Bowel cancer “melted away” after immunotherapy, then stayed away
A study found that a short course of immunotherapy before surgery kept patients with a specific type of bowel cancer free of recurrence for nearly three years. None of the 32 participants had cancer return, even those with small remaining traces of the disease. The treatment showed better results than standard post-surgery chemotherapy.
A clinical trial tested immunotherapy before surgery for bowel cancer and found it kept patients cancer-free for three years. The treatment was more effective than standard chemotherapy in preventing cancer return.
The results suggest a new, more effective treatment option for some bowel cancer patients, potentially reducing the need for harsher therapies and improving long-term outcomes.
The study shows how medical advances can offer hope and better care for patients, highlighting the potential for personalized treatment and improved survival rates.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.